Skip to content

Development of a Risk Prediction Model for OSA-Related Hypertension

Development of a Risk Prediction Model for OSA-Related Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120554
Enrollment
Unknown
Registered
2026-03-17
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea (OSA) is a common sleep disorder characterized by repeated partial or complete collapse of the upper airway during sleep, leading to episodes of apnea or hypopnea. OSA not only affects sleep quality but is also closely associated with various serious complications, particularly hypertension. Studies indicate a bidirectional causal relationship between OSA and hypertension.

Interventions

Non-hypertension group:None

Sponsors

The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.AHI >= 5 events/hour; 3.Newly diagnosed OSA patients with no prior OSA-related treatment;

Exclusion criteria

Exclusion criteria: 1.Incomplete baseline data; 2.Presence of common etiologies of secondary hypertension; 3.History of snoring or breathing pauses shorter than the history of hypertension; 4.Central sleep apnea (central apnea-hypopnea index >=5 events/hour); 5.Comorbidities such as severe heart failure or multiple organ dysfunction;

Design outcomes

Primary

MeasureTime frame
Nomogram Performance (including ROC Curve, Hosmer-Lemeshow Test, Clinical Decision Curve);

Secondary

MeasureTime frame
Baseline Demographics and Medical History;Sleep Respiratory Parameters (including Apnea-Hypopnea Index, Total Respiratory Events, Peripheral Oxygen Saturation);Clinical Laboratory Results (including Total Bilirubin, Direct Bilirubin, Indirect Bilirubin, Albumin);

Countries

China

Contacts

Public ContactLiu Kezheng

The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology

liukezheng2006@126.com+86 472 2178789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026